XENE
Xenon Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · CA
$59.69
−1.18%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 501.10x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.65x
- Price / sales
- —
- Price / cash flow
- -17.13x
Enterprise value
- Enterprise value
- $4.9B
- EV / sales
- —
- EV / EBITDA
- -11.65x
- EV / EBIT
- -11.00x
- Market cap
- $5.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026